Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 19.78
-0.87 (-4.21%)
Oct 13, 2026, 12:36 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.33 billion as of October 12, 2026. It is the 23,187th most valuable company in the world and the 286th biggest in Sweden. Its market cap has decreased by 3.82% in one year.
Market Cap
1.33B
Enterprise Value
1.25B
Revenue
135.89M
Global Rank
Country Rank
#286 Sweden
PE Ratio
66.70
ChartMarket Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.33B, an increase of 17,658.98%. That is a compound annual growth rate of 32.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.33B | -4.95% |
| Dec 30, 2025 | 1.40B | -13.18% |
| Dec 30, 2024 | 1.62B | -52.50% |
| Dec 29, 2023 | 3.40B | 13.17% |
| Dec 30, 2022 | 3.01B | -37.05% |
| Dec 30, 2021 | 4.78B | 131.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.68B |
| Vicore Pharma Holding AB | 2.58B |
| BioInvent International AB | 1.52B |
| Flerie AB | 1.31B |
| Saniona AB | 1.25B |
| AlzeCure Pharma AB | 979.07M |
| SynAct Pharma AB | 964.29M |
| Infant Bacterial Therapeutics AB | 959.17M |